Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Login Sign up free
Home Screener Maps Charts News Groups Insider Futures Forex Crypto Portfolio Calendar
Pricing

The Finviz API:   Higher Limits, Clearer Data, and More Ways to Connect

Get Started Now
Market News Market Pulse Stocks News ETF News Crypto News

Sutro Biopharma, Inc.

Contributing Author

Recent Articles by Sutro Biopharma, Inc.

Oct-12
Sutro Biopharma Announces Participation at the 17th Annual World ADC Conference STRO -6.94% GlobeNewswire
Sep-29
Sutro Biopharma Appoints Lucas Donigian as Senior Vice President, Business Development STRO GlobeNewswire
Aug-12
Sutro Biopharma Reports Second Quarter 2026 Financial Results and Provides Early Update on STRO-004 Phase 1 Study STRO -14.94% GlobeNewswire
May-14
Sutro Biopharma Reports First Quarter 2026 Financial Results and Business Highlights STRO GlobeNewswire
Apr-19
Sutro Biopharma Presents Promising Preclinical Data Across its Pipeline of Next-Generation Single and Dual-Payload ADC Programs at AACR 2026 STRO GlobeNewswire
Mar-23
Sutro Biopharma Reports Full Year 2025 Financial Results and Business Highlights STRO STRO +10.50% GlobeNewswire
Feb-25
Sutro Biopharma to Participate in Upcoming Investor Conferences STRO GlobeNewswire
Feb-23
Sutro Biopharma Announces Participation at the 16th World ADC London Summit STRO GlobeNewswire
Feb-10
Sutro Biopharma Announces Pricing of $110.0 million Underwritten Offering STRO +11.87% GlobeNewswire
Jan-07
Sutro Biopharma to Present at the 44th Annual J.P. Morgan Healthcare Conference STRO GlobeNewswire
Dec-17
Sutro Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement STRO -6.93% GlobeNewswire
Dec-16
Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) STRO GlobeNewswire
Dec-03
Sutro Biopharma Announces First Cohort of Patients Dosed in Phase 1 Trial of STRO-004, a Next-Generation Tissue Factor ADC, in TF-Expressing Solid Tumors STRO +19.21% GlobeNewswire
Dec-01
Sutro Biopharma Announces 1-for-10 Reverse Stock Split STRO -12.82% GlobeNewswire
Nov-12
Sutro Biopharma Highlights Next-Generation ADC Innovation at Virtual R&D Day STRO GlobeNewswire
Nov-06
Sutro Biopharma Reports Third Quarter 2025 Financial Results and Business Highlights STRO STRO -13.36% GlobeNewswire
Nov-05
Sutro Biopharma to Host Virtual Research & Development Day on November 12, 2025 STRO GlobeNewswire
Nov-03
Sutro Biopharma Announces Participation at the 16th Annual World ADC Conference STRO GlobeNewswire
Sep-29
Sutro Biopharma Announces Operational Restructuring Intended to Extend Cash Runway through Key Milestones STRO GlobeNewswire
Aug-07
Sutro Biopharma Reports Second Quarter 2025 Financial Results and Business Highlights STRO GlobeNewswire
Jul-22
Sutro Biopharma Announces Research Collaboration with the FDA to Advance Regulatory Standards for Antibody Drug Conjugates STRO +7.12% GlobeNewswire
Jun-02
Sutro Biopharma Appoints Greg Chow as Chief Financial Officer STRO GlobeNewswire
May-08
Sutro Biopharma Reports First Quarter 2025 Financial Results and Business Highlights STRO STRO -9.06% GlobeNewswire
May-01
Sutro Biopharma to Participate in Upcoming Investor Conferences STRO GlobeNewswire
Affiliate • Advertise • API and Exports • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)